AURA (STOCKS)
Aura Biosciences, Inc. Common Stock
$6.910000
+0.110000 (+1.62%)
Prev close: $6.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Elisabet de los Pinos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $442.32M
- Employees
- 106
- P/E (TTM)
- -3.81
- P/B (TTM)
- 3.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.40 | $-0.48 | +0.0758 | +15.93% |
|
Jun 2025 (Q2)
|
$-0.47 | $-0.47 | -0.0033 | -0.71% |
|
Mar 2025 (Q1)
|
$-0.55 | $-0.50 | -0.0490 | -9.78% |
|
Dec 2024 (Q4)
|
$-0.52 | $-0.45 | -0.0676 | -14.94% |
Financial Statements
| Nonoperating Income/Loss | $6.71M |
| Research and Development | $90.30M |
| Operating Income/Loss | -$112.79M |
| Income/Loss From Continuing Operations After Tax | -$106.19M |
| Income/Loss From Continuing Operations Before Tax | -$106.08M |
| Income Tax Expense/Benefit | $108.00K |
| Income Tax Expense/Benefit, Current | $108.00K |
| Interest Income/Expense After Provision For Losses | $6.63M |
| Net Income/Loss | -$106.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$106.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$106.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.76 |
| Diluted Earnings Per Share | -$1.76 |
| Basic Average Shares | 60,337,608 |
| Diluted Average Shares | 60,337,608 |
| Assets | $169.43M |
| Current Assets | $149.74M |
| Cash | $144.20M |
| Other Current Assets | $5.54M |
| Noncurrent Assets | $19.69M |
| Fixed Assets | $2.62M |
| Other Non-current Assets | $17.07M |
| Liabilities | $32.52M |
| Current Liabilities | $18.38M |
| Accounts Payable | $1.55M |
| Other Current Liabilities | $16.83M |
| Noncurrent Liabilities | $14.13M |
| Equity | $136.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $136.91M |
| Liabilities And Equity | $169.43M |
| Net Cash Flow From Operating Activities | -$84.74M |
| Net Cash Flow From Operating Activities, Continuing | -$84.74M |
| Net Cash Flow From Investing Activities | $35.60M |
| Net Cash Flow From Investing Activities, Continuing | $35.60M |
| Net Cash Flow From Financing Activities | $77.16M |
| Net Cash Flow From Financing Activities, Continuing | $77.16M |
| Net Cash Flow | $28.01M |
| Net Cash Flow, Continuing | $28.01M |
| Comprehensive Income/Loss | -$106.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$106.56M |
| Other Comprehensive Income/Loss | -$365.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$365.00K |